Schizophrenia: all 3,539 studies

Page 15 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With SchizophreniaCompletedNCT05848700Phase 1
• Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaCompletedNCT05838625Phase 3
• Metformin Treatment on Cognitive Impairment of SchizophreniaCompletedNCT05838573Phase 3
• Dasatinib Plus Quercetin for Accelerated Aging in Mental DisordersActive, not recruitingNCT05838560Phase 2
• Theory Based Integrated Program on Medication Adherence Among Community Dwelling SchizophreniaCompletedNCT05835583Not applicable
• Acupuncture Treatment for Schizophrenia-related Central ObesityStatus unknownNCT05833009Not applicable
• Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.Status unknownNCT05824117Not applicable
• Study of Experience of High-frequency Repetitive TranscranialCompletedNCT05809882Not applicable
• Tele-group Cognitive Behavioural Family Intervention for People With Schizophrenia and Their Families (Feasibility tgCBFI)CompletedNCT05808244Not applicable
• Safety and Efficacy of Virtual Reality Mindfulness in Patients With PsychosisCompletedNCT05784948Not applicable
• Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005CompletedNCT05779241Phase 3
• Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and PostpartumCompletedNCT05766007
• Effectiveness of Behavioral Activation Treatment for SchizophreniaStatus unknownNCT05764148Not applicable
• Effect of Applying Cognitive Defusion Techniques on Mindful Awareness, Cognitive Fusion and Believability of Delusions Among Clients With SchizophreniaCompletedNCT05759091Not applicable
• Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in SchizophreniaActive, not recruitingNCT05748990Not applicable
• The Effect of Developing Psychological Resilience on Functionality in Schizophrenia PatientsCompletedNCT05739344Not applicable
• Technology-Assisted Implementation of a Mobile Health Program for Serious Mental IllnessCompletedNCT05725785Not applicable
• Alexithymia Intervention for SuicideTerminatedNCT05724953Phase 1
• Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in SchizophreniaTerminatedNCT05724810Not applicable
• Dance/Movement Therapy for Bone Mineral Density in SchizophreniaCompletedNCT05716802Not applicable
• eMove - Dance/Movement Therapy StudyCompletedNCT05712928Not applicable
• The Impact of Gaming on Functioning Among People With SchizophreniaStatus unknownNCT05707689Not applicable
• EEG Outcomes From Cognitive Behavioural Therapy for PsychosisCompletedNCT05703698Not applicable
• tDCS Combined With rTMS for Negative Symptoms of SchizophreniaStatus unknownNCT05695144Not applicable
• A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)CompletedNCT05686239Phase 2
• "InMotion" - Physical Training With Creative Movement as an Intervention for Adults With SchizophreniaActive, not recruitingNCT05673941Not applicable
• Service User and Staff Views on Digital Remote Monitoring for PsychosisCompletedNCT05670197
• Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug DiscontinuationCompletedNCT05667961
• State Representation in Early Psychosis - Project 4CompletedNCT05664594Not applicable
• Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical AntipsychoticsCompletedNCT05663749Phase 4
• The Effect of Recognition and Expression of Emotions Program Applied to Schizophrenia PatientsCompletedNCT05662137Not applicable
• Promoting Cognitive Health in SchizophreniaCompletedNCT05661448Not applicable
• Context-Aware Mobile Intervention for Social Recovery in Serious Mental IllnessCompletedNCT05660070Not applicable
• Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)CompletedNCT05658510Phase 3
• Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for SchizophreniaTerminatedNCT05654870Phase 3
• A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in SchizophreniaStatus unknownNCT05646264Phase 4
• Ascertaining Diagnosis Classification With Elicited SpeechCompletedNCT05601063
• Linguistic Predictors of Outcomes in PsychosisCompletedNCT05601050
• Optimal rTMS for Cognitive Deficits and Negative Symptoms in SchizophreniaStatus unknownNCT05599373Not applicable
• Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of SchizophreniaCompletedNCT05582980Not applicable
• ToM Psychotherapy and Brain Networks in EOSCompletedNCT05577338Not applicable
• Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early PsychosisStatus unknownNCT05571228Not applicable
• Accelerated TMS in PsychosisSuspendedNCT05567848Phase 1/2
• Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With SchizophreniaCompletedNCT05563818
• Metacognitive Intervention for Individuals With Severe Mental DisordersCompletedNCT05556941Not applicable
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With SchizophreniaCompletedNCT05545111Phase 2
• A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With SchizophreniaCompletedNCT05542264Phase 1
• Intra-cortical Inhibition and Cognitive Deficits in SchizophreniaStatus unknownNCT05542212Not applicable
• Remote State Representation in Early PsychosisCompletedNCT05538832Early Phase 1
• Feasibility Trial of a Lifestyle Intervention for CHR-PCompletedNCT05532683Not applicable
• Effects of Psyllium on Constipation in Schizo-phrenic: A Randomized Controlled Crossover TrialCompletedNCT05528146Not applicable
• Prebiotic Treatment in People With SchizophreniaActive, not recruitingNCT05527210Not applicable
• The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation CenterCompletedNCT05517460Not applicable
• VLT-015 in Patients With SchizophreniaCompletedNCT05516121Phase 1
• Dance and Movement Therapy in Patients With SchizophreniaCompletedNCT05500651Not applicable
• Risk Prediction Model of Cardiovascular Events in Patients With SchizophreniaStatus unknownNCT05498571
• Investigating the Cognitive Source of Visual Working Memory Impairment in SchizophreniaCompletedNCT05496413Not applicable
• Mindfulness, Empathy and the Oxytocinergic System in Persons With SchizophreniaStatus unknownNCT05491486Not applicable
• 7-week Study With CT-155 in People With SchizophreniaCompletedNCT05486312Not applicable
• A Study of HS-10380 in Chinese ParticipantsStatus unknownNCT05480592Phase 1
• Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseCompletedNCT05480046
• Risk of Breakthrough Symptoms With Long-Acting Injectable MedicationsCompletedNCT05473741
• Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia PatientsWithdrawnNCT05469815Not applicable
• Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in SchizophreniaCompletedNCT05464563Not applicable
• A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With SchizophreniaCompletedNCT05463770Phase 1
• PET Imaging Study of α7 and α4β2-nAChR in SchizophreniaTerminatedNCT05462340Phase 1
• Evaluation of Physical Activity, Physical Fitness, and Quality of Life in Patients With SchizophreniaCompletedNCT05449977
• iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.Status unknownNCT05448430Not applicable
• Exploratory Study of a Digital Therapeutics in People With SchizophreniaCompletedNCT05438160Not applicable
• Does tDCS Change Synaptic Density in the Brains of Patients With SchizophreniaActive, not recruitingNCT05435300
• Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive OutcomesCompletedNCT05414058Phase 2
• Computerized Cognitive Remediation Therapy in Adolescents With a First Psychotic EpisodeStatus unknownNCT05405946Not applicable
• A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) StandardCompletedNCT05402111Phase 1
• tDCS and Executive Function Training for SchizophreniaWithdrawnNCT05389345Not applicable
• A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in JapanTerminatedNCT05359081Phase 3
• Accelerated cTBS on Metabolic Dysfunction in People With SchizophreniaStatus unknownNCT05358899Not applicable
• Is Cognitive Training an Option?CompletedNCT05352568Not applicable
• Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)Status unknownNCT05351736Phase 4
• eMotiph: E-mental Health Solution for Patients With SchizophreniaCompletedNCT05345977Not applicable
• Sensitivity, Threshold, Tolerance and Pain Recognition in Schizophrenia Patients and Their Relatives.Status unknownNCT05345548Not applicable
• Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in SchizophreniaCompletedNCT05342727Phase 1
• Cognitive and Balance Dual Task Training for People With SchizophreniaCompletedNCT05341804Not applicable
• Schizophrenia Treatment With PhotoneuromodulationCompletedNCT05339347Phase 2
• Exercise Target Brain Oscillations in PsychosisWithdrawnNCT05338424
• Deep Brain Stimulation Recovery in Treatment-Resistant SchizophreniaActive, not recruitingNCT05337904Not applicable
• Soft Tissue Tenderness and Fibromyalgia Among Schizophrenia Patients.Status unknownNCT05328518
• A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With SchizophreniaCompletedNCT05326347Phase 3
• The Effect of Progressive Muscle Relaxation on Psychological Symptoms and Mental Well-Being in Patients With SchizophreniaStatus unknownNCT05324865Not applicable
• The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of SchizophreniaCompletedNCT05322031Phase 4
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT05321602Phase 1
• Intervention Effect of Shen-based Qigong Exercise on Residual Symptoms of SchizophreniaStatus unknownNCT05310955Not applicable
• Needs-tailored Nurse-led Recovery Program for Community-dwelling People With SchizophreniaCompletedNCT05304780Not applicable
• An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaCompletedNCT05304767Phase 3
• Effect of Nicotine Transdermal Patch on Cognitive Function and Glycolipid Metabolism in Non-smoking SchizophreniaStatus unknownNCT05301660Early Phase 1
• Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionCompletedNCT05300633Not applicable
• Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory SchizophreniaCompletedNCT05282329Not applicable
• What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in SchizophreniaCompletedNCT05282186Not applicable
• Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO TrialCompletedNCT05281640Not applicable
• Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With SchizophreniaCompletedNCT05278156Phase 2
• State Representation in Early PsychosisCompletedNCT05273164

← Schizophrenia overview